FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Richard Cox derails sex offender case, once again

Biden accuses Trump of erasing history and squandering US leadership role on global stage: ‘Dark days’

ICE blasts Washington mayor over directive restricting immigration enforcement

Dem Washington House majority leader apologizes for being ‘impaired’ during budget hearing

Man accused of spraying anti-ICE graffiti at Oklahoma Capitol is registered child sex offender; charges filed

Hegseth bans military from attending Princeton, Columbia, other elite universities: ‘Wokeness and weakness’

Trump picks up Whataburger for Air Force One and jokes about being poisoned after Texas speech

Luigi Mangione escapes federal death penalty after federal prosecutors decline to appeal judge’s ruling

Trump says he plans to order federal ban on Anthropic AI after company refuses Pentagon demands

DHS funding stalemate thaws as White House sends Democrats ‘serious’ counteroffer

‘The Earth Shook’: Geologists Say They Have Confirmed Earthquake Around Time Of Jesus’ Death as Quoted in Scripture

Fox News True Crime Newsletter: New Nancy Guthrie video, Caleb Flynn’s charges, missing mom arrested

Curriculum Standards Should Mandate that Teachers Teach the Truth About Socialism

BREAKING: Bill Clinton Drops Bombshell Statement in Epstein Testimony – Helps Exonerate Trump Completely

ICE arrests illegal immigrant training as Pennsylvania corrections officer suspected of rape

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”